Creating a new imaging tool to study Alzheimer's disease
Development of Highly Multiplexed Raman Imaging Platform for Alzheimer’s Disease
This study is working on a new imaging tool to look closely at brain tissue from people with Alzheimer's, helping us see how the immune system and brain cells change with the disease, which could lead to better treatments in the future.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11055758 on NIH RePORTER |
What this research studies
This research focuses on developing a cutting-edge imaging platform that can analyze multiple biomarkers in brain tissue samples from Alzheimer's disease patients. By using advanced nanoparticle technology, the study aims to visualize and understand the complex immune responses and cellular changes associated with Alzheimer's. This innovative approach will allow researchers to capture detailed information about the brain's pathology in a single imaging session, which could lead to better therapeutic strategies. The project is designed to enhance our understanding of how the immune system interacts with Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those showing early signs of cognitive decline.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques to study neurodegenerative diseases, indicating that this approach could yield valuable insights.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Eremina, Olga E. — University of Southern California
- Study coordinator: Eremina, Olga E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.